These findings highlight MCAM as a key mediator of fibrosis through Wnt/β-catenin signaling and suggest that its blockade with AA98 is a promising strategy to stop or reverse dermal fibrosis in SSc [179]. Here, MCAM is linked to systemic sclerosis.